Likewise, VD-3-treated TAC mice exhibited a dose-dependent inhibition of cardiomyocyte apoptosis, myocardial superoxide production, and mRNA expression of Nox2, Nox4, and p22phox compared to vehicle-treated TAC mice [77]. Here, CYBA is linked to persistent truncus arteriosus.